搜索筛选:
搜索耗时0.0748秒,为你在为你在102,285,761篇论文里面共找到 4 篇相符的论文内容
发布年度:
Nedaplatin/Gemcitabine Versus Carboplatin/Gemcitabine in Treatment of Advanced Non-small Cell Lung C
[期刊论文] 作者：Jin-ji Yang,Qing Zhou,Ri-qiang Liao,Yi-sheng Huang,Chong-rui Xu,Zhen Wang,Bin-chao Wang,Hua-jun Chen,,
来源：中国癌症研究（英文版） 年份：2012
Objective:To evaluate the efficacy and safety of nedaplatin/gemcitabine (NG) and carboplatin/gemcitabine (CG) in the management of untreated advanced non-small...
Study design: A retrospective study to evaluate the diagnosis of EGFR mutations detected by the coba
[会议论文] 作者：Qing Zhou,Zhi-hong Chen,Yi-chen Zhang,Chong-rui Xu,Qiu-yi Zhang,Wen-zhao Zhong,Jin-ji Yang,Jian Su,Yi-long,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: Activating mutations in the gene encoding EGFR occur primarily in non-small cell lung cancer (NSCLC) and result in constitutive activation of the...
Study design: A retrospective study to evaluate the diagnosis of EGFR mutations detected by the coba
[会议论文] 作者：Qing Zhou,Zhi-hong Chen,Qiu-yi Zhang,Jian Su,Jin-ji Yang,Chong-rui Xu,Yi-chen Zhang,Wen-zhao Zhong,Yi-long,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: Activating mutations in the gene encoding EGFR occur primarily in non-small cell lung cancer (NSCLC) and result in constitutive activation of the kinase activity of the EGFR protein, thereb...
Survivals in Advanced EGFR-Mutant NSCLC Patients Treated with First-Generation EGFR TKIs followed by
[会议论文] 作者：Yihui Yao,Jiang-Tao Cheng,Jin-Ji Yang,Jin Kang,Xiang-Meng Li,Yi-Long Wu,Qing Zhou,Xu-Chao Zhang,Chong-Rui Xu,
来源：2019中国肿瘤学大会 年份：2019
...
相关搜索：
